A Multicenter, Randomized, Double-Blind Phase 3 Trial of KDF1901 in Patients With Essential Hypertension

NCT07116863 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

286

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: KDF1901-R0
DRUG: KDF1901-L
DRUG: KDF1901
DRUG: KDF1901-R1

Sponsor

Kyungdong Pharmaceutical Co., Ltd.